254 related articles for article (PubMed ID: 31937944)
1. Reduction of the therapeutic dose of silencing RNA by packaging it in extracellular vesicles via a pre-microRNA backbone.
Reshke R; Taylor JA; Savard A; Guo H; Rhym LH; Kowalski PS; Trung MT; Campbell C; Little W; Anderson DG; Gibbings D
Nat Biomed Eng; 2020 Jan; 4(1):52-68. PubMed ID: 31937944
[TBL] [Abstract][Full Text] [Related]
2. Functional Delivery of Lipid-Conjugated siRNA by Extracellular Vesicles.
O'Loughlin AJ; Mäger I; de Jong OG; Varela MA; Schiffelers RM; El Andaloussi S; Wood MJA; Vader P
Mol Ther; 2017 Jul; 25(7):1580-1587. PubMed ID: 28392161
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression.
Pi F; Binzel DW; Lee TJ; Li Z; Sun M; Rychahou P; Li H; Haque F; Wang S; Croce CM; Guo B; Evers BM; Guo P
Nat Nanotechnol; 2018 Jan; 13(1):82-89. PubMed ID: 29230043
[TBL] [Abstract][Full Text] [Related]
4. GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain.
Dar GH; Mendes CC; Kuan WL; Speciale AA; Conceição M; Görgens A; Uliyakina I; Lobo MJ; Lim WF; El Andaloussi S; Mäger I; Roberts TC; Barker RA; Goberdhan DCI; Wilson C; Wood MJA
Nat Commun; 2021 Nov; 12(1):6666. PubMed ID: 34795295
[TBL] [Abstract][Full Text] [Related]
5. Chitosan-based nanoparticles for mucosal delivery of RNAi therapeutics.
Martirosyan A; Olesen MJ; Howard KA
Adv Genet; 2014; 88():325-52. PubMed ID: 25409611
[TBL] [Abstract][Full Text] [Related]
6. Endosomolytic and Tumor-Penetrating Mesoporous Silica Nanoparticles for siRNA/miRNA Combination Cancer Therapy.
Wang Y; Xie Y; Kilchrist KV; Li J; Duvall CL; Oupický D
ACS Appl Mater Interfaces; 2020 Jan; 12(4):4308-4322. PubMed ID: 31939276
[TBL] [Abstract][Full Text] [Related]
7. Preparation and Isolation of siRNA-Loaded Extracellular Vesicles.
Vader P; Mäger I; Lee Y; Nordin JZ; Andaloussi SE; Wood MJ
Methods Mol Biol; 2017; 1545():197-204. PubMed ID: 27943216
[TBL] [Abstract][Full Text] [Related]
8. Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics.
Gentile E; Oba T; Lin J; Shao R; Meng F; Cao X; Lin HY; Mourad M; Pataer A; Baladandayuthapani V; Cai D; Roth JA; Ji L
Oncotarget; 2017 Jul; 8(29):48222-48239. PubMed ID: 28637023
[TBL] [Abstract][Full Text] [Related]
9. Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins.
Boden D; Pusch O; Silbermann R; Lee F; Tucker L; Ramratnam B
Nucleic Acids Res; 2004; 32(3):1154-8. PubMed ID: 14966264
[TBL] [Abstract][Full Text] [Related]
10. Functional siRNA Delivery by Extracellular Vesicle-Liposome Hybrid Nanoparticles.
Evers MJW; van de Wakker SI; de Groot EM; de Jong OG; Gitz-François JJJ; Seinen CS; Sluijter JPG; Schiffelers RM; Vader P
Adv Healthc Mater; 2022 Mar; 11(5):e2101202. PubMed ID: 34382360
[TBL] [Abstract][Full Text] [Related]
11. Production of Extracellular Vesicles Loaded with Therapeutic Cargo.
Lamichhane TN; Jay SM
Methods Mol Biol; 2018; 1831():37-47. PubMed ID: 30051423
[TBL] [Abstract][Full Text] [Related]
12. RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.
Lee TJ; Haque F; Shu D; Yoo JY; Li H; Yokel RA; Horbinski C; Kim TH; Kim SH; Kwon CH; Nakano I; Kaur B; Guo P; Croce CM
Oncotarget; 2015 Jun; 6(17):14766-76. PubMed ID: 25885522
[TBL] [Abstract][Full Text] [Related]
13. Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach.
Thanki K; Zeng X; Justesen S; Tejlmann S; Falkenberg E; Van Driessche E; Mørck Nielsen H; Franzyk H; Foged C
Eur J Pharm Biopharm; 2017 Nov; 120():22-33. PubMed ID: 28756280
[TBL] [Abstract][Full Text] [Related]
14. Commitment of Annexin A2 in recruitment of microRNAs into extracellular vesicles.
Hagiwara K; Katsuda T; Gailhouste L; Kosaka N; Ochiya T
FEBS Lett; 2015 Dec; 589(24 Pt B):4071-8. PubMed ID: 26632510
[TBL] [Abstract][Full Text] [Related]
15. Promising RNA-based cancer gene therapy using extracellular vesicles for drug delivery.
Xue VW; Wong SCC; Song G; Cho WCS
Expert Opin Biol Ther; 2020 Jul; 20(7):767-777. PubMed ID: 32125904
[TBL] [Abstract][Full Text] [Related]
16. Loading of Extracellular Vesicles with Hydrophobically Modified siRNAs.
Didiot MC; Haraszti RA; Aronin N; Khvorova A
Methods Mol Biol; 2018; 1740():199-214. PubMed ID: 29388146
[TBL] [Abstract][Full Text] [Related]
17. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
[TBL] [Abstract][Full Text] [Related]
18. Hydrophobicity of Lipid-Conjugated siRNAs Predicts Productive Loading to Small Extracellular Vesicles.
Biscans A; Haraszti RA; Echeverria D; Miller R; Didiot MC; Nikan M; Roux L; Aronin N; Khvorova A
Mol Ther; 2018 Jun; 26(6):1520-1528. PubMed ID: 29699940
[TBL] [Abstract][Full Text] [Related]
19. Biocompatible gelatin nanoparticles for tumor-targeted delivery of polymerized siRNA in tumor-bearing mice.
Lee SJ; Yhee JY; Kim SH; Kwon IC; Kim K
J Control Release; 2013 Nov; 172(1):358-366. PubMed ID: 24036198
[TBL] [Abstract][Full Text] [Related]
20. Self-assembled RNA interference microsponges for efficient siRNA delivery.
Lee JB; Hong J; Bonner DK; Poon Z; Hammond PT
Nat Mater; 2012 Feb; 11(4):316-22. PubMed ID: 22367004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
